Could a simple blood draw speed up emergency care?

NCT ID NCT07769645

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This study looks at whether taking blood samples before a doctor's first assessment can reduce how long patients spend in the emergency department. Researchers will compare the length of stay for patients who had early blood draws versus those who didn't, using data from over 28,000 visits. The goal is to see if this simple step can help ease overcrowding and improve patient flow.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Anticipated blood sampling (drawing blood before the doctor's first assessment)
What this could lead to
If effective, this simple change could help emergency departments move patients through faster, easing crowding and potentially improving outcomes.
What could go wrong
This is a retrospective observational study, so it can't prove cause and effect. Earlier studies have shown mixed results, and the benefit may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

28,421 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients admitted in ED between 01/01/2025and 12/31/2025 wha had blood sampling.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years and older * Blood sampling realized in ED Exclusion Criteria: * Patients without triage * Patients without complaint * Patient's refusal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood sampling are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crowding Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalire de Roubaix

    Roubaix, 59100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.